You searched for "stone"
BXTAccelyon becomes global distribution partner for new online prostate MRI self-learning tool to enhance prostate cancer diagnosis
BXTAccelyon, the leading low dose rate (LDR) brachytherapy partner to hospitals and clinics worldwide, and distribution partner for PrecisionPoint™, the...Upper urinary tract urothelial cell carcinoma
Case 1 A 64-year-old man presents to the haematuria clinic with visible haematuria, on a background of a 40 pack-year smoking history and family history of bowel cancer in his sister at the age of 48. A CT was performed...In conversation with Asif Muneer at BAUS 2019
We chat to Asif Muneer, Consultant Urological Surgeon and BAUS Honorary Secretary Elect. Click the image below to see his answers to our questions.In conversation with Veeru Kasivisvanathan at BAUS 2019
We chat to Veeru Kasivisvanathan, Urology Specialist Registrar and Chair of BURST. Click the image below to see his answers to our questions.In conversation with Ben Challacombe at BAUS 2019
We catch up with Ben Challacombe, Consultant Urological Surgeon, Guy’s and St Thomas’s, London at BAUS 2019. Click the image below to see his answers to our questions.Workshop news update from the upcoming BAUN Conference at the ACC in Liverpool on 4 - 5 November
The British Association of Urological Nurses (BAUN) Conference 2024 takes place from 4-5 November at the ACC in Liverpool. In addition, popular pre-conference workshops are taking place on Sunday 3 November.Developing a risk calculator to predict cancer in patients with haematuria: The IDENTIFY Study
Patients with haematuria require investigations to rule out urinary tract cancer. We know that the most common cancer found during these investigations is bladder cancer, whereas upper tract cancers such as renal cell carcinoma and upper urinary tract urothelial cancer...Bouncing Back: support, mentorship and advice for those unsuccessful in urology ST3 national selection
The 2018 BAUS Annual Scientific Meeting in Liverpool delivered the first session for applicants unsuccessful in urology ST3 national selection. The session was organised and run by Luke Forster, Core Training Liaison Representative, along with several trainees. Background The concept...
Intravesical cytosine arabinoside + Mitomycin C for bladder cancer – is it beneficial?
Mitomycin C (MMC) is often used as an intravesical therapy for low / intermediate risk non-muscle invasive bladder cancer. This randomised controlled trial (RCT) was designed to assess the safety and efficacy of MMC + cytosine arabinoside (Ara-C). Ara-C was...
Is TRUS and biopsy obsolete as a diagnostic test for prostate cancer: refining the perineal biopsy technique?
Whilst there has been a dramatic shift in how patients are investigated for potential prostate cancer, transrectal ultrasound (TRUS) and biopsy remains the most commonly used technique for tissue sampling. In this single centre, retrospective analysis, 634 men, over a...
